7
Views
1
CrossRef citations to date
0
Altmetric
Research Article

PLATELET ACTIVATING FACTOR ANTAGONISM IN PURE SKIN FLAPS EXPOSED TO ISCHAEMIA-REPERFUSION INJURY

Pages 155-161 | Published online: 08 Jul 2009

REFERENCES

  • Abbassi O, Kishimoto TK, McIntire LV, Anderson DC, Smith CW. E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest 1993; 92: 2719–2730.
  • Alloatti G, Montrucchio G, Camussi G. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. J Pharmacol Exp Ther 1994; 269: 766–771.
  • Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypox-ia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993; 264: C1102– C1110.
  • Belkin M, LaMorte WL, Wright JG, Hobson RW. The role of leukocytes in the pathophysiol-ogy of skeletal muscle ischemic injury. J Vasc Surg 1989; 10: 14–18.
  • Bienvenu K, Harris N, Granger DN. Modulation of leukocyte migration in mesenteric interstitium. Am J Physiol 1994; 267: H1573–H1577.
  • Black SC, Driscoll EM, Lucchesi BR. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage. J Cardiovasc Pharmacol 1992; 20: 997–1005.
  • Borregaard N, Kjeldsen L, Sengelov H et al. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 1994; 56: 80–87.
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206–209.
  • Daniel RK, Kerrigan CL. The omnipotential pig buttock flap. Plast Reconstr Surg 1982; 70: 11– 15.
  • Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, Braquet P. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfu-sion. Free Radic Res Commun 1991; 12–13: 725–735.
  • Hansen PR, Stawski G. Neutrophil mediated damage to isolated myocytes after anoxia and reoxygenation. Cardiovasc Res 1994; 28: 565– 569.
  • Hwang SB. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem 1988; 263: 3225–3233.
  • Ioculano M, Squadrito F, Altavilla D et al. Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocar-dial ischemia and reperfusion in rats. J Cardio-vasc Pharmacol 1994; 23: 7–12.
  • Kirschner RE, Fyfe BS, Hoffman LA, Chiao JJC, Davis JM, Fantini GA. Ischemia-reperfusion injury in myocutaneous flaps: role of leukocytes and leukotrienes. Plast Reconstr Surg 1997; 99: 1485–1493.
  • Ko W, Lang D, Hawes AS, Zelano JA, Isom OW, Krieger KH. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. J Surg Res 1993; 55: 504–515.
  • Korthuis RJ, Grisham MB, Granger DN. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 1988; 254: H823–H827.
  • Kroll SS, Schusterman MA, Reece GP et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 1996; 98: 1230–1241.
  • Lee C, Kerrigan CL. Ibuprofen: treatment of ischemic musculocutaneous flaps. Ann Plast Surg 1994; 32: 300–304.
  • Lee C, Kerrigan CL, Picard-Ami LAJ. Cyclo-phosphamide-induced neutropenia; effect on postischemic skin-flap survival. Plast Reconstr Surg 1992; 89: 1092–1097.
  • Leong LL, Sturm MJ, Papadimitriou JM, Stephens CJ, Taylor RR. The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog. J Mol Cell Cardiol 1992; 24: 641–649.
  • Lepore DA, Knight KR, Stewart AG, Riccio M, Morrison WA. Platelet-activating factor (PAF) receptor antagonism by WEB 2170 improves the survival of ischaemic skeletal muscle. Ann Acad Med Singapore 1995; 24: 63–67.
  • Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott S, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045–2055.
  • Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223–234.
  • Ma XL, Weyrich AS, Krantz S, Lefer AM. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfu-sion. J Pharmacol Exp Ther 1992; 260: 1229– 1236.
  • McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92–99.
  • McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A 1986; 83: 2204–2208.
  • McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-activating factor and prosta-cyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 1985; 76: 271–280.
  • Milhoan KA, Lane TA, Bloor CM. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Am J Physiol 1992; 263: H956–H962.
  • Montrucchio G, Alloatti G, Mariano F et al. Role of platelet-activating factor in polymorpho-nuclear neutrophil recruitment in reperfused ischemic rabbit heart. Am J Pathol 1993; 142: 471–480.
  • Morris SF:. Pathogenesis and treatment of ischemia-induced tissue injury in the latissimus dorsi myocutaneous flap in pigs. Toronto: Institute of Medical Science, University of Toronto, 1988. Thesis.
  • Myers CL, Wertheimer SJ, Schembri King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992; 263: C767–C772.
  • Nathan C, Srimal S, Farber C et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989; 109: 1341–1349.
  • Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112: 749– 759.
  • Petrasek PF, Liauw S, Romaschin AD, Walker PM. Salvage of postischemic skeletal muscle by monoclonal antibody blockade of neutrophil adhesion molecule CD18. J Surg Res 1994; 56: 5–12.
  • Picard-Ami LAJ, Thomson JG, Kerrigan CL. Critical ischemia times and survival patterns of experimental pig flaps. Plast Reconstr Surg 1990; 86: 739–743.
  • Prescott SM, Zimmerman GA, McIntyre TM. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A 1984; 81: 3534–3538.
  • Raschke P, Becker BF. Adenosine and PAF dependent mechanisms lead to myocardial re-perfusion injury by neutrophils after brief ischaemia. Cardiovasc Res 1995; 29: 569–576.
  • Read RA, Moore EE, Moore FA, Carl VS, Banerjee A. Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. Surgery 1993; 114: 308–313.
  • Salemark L. International survey of current microvascular practices in free tissue transfer and replantation surgery. Microsurgery 1991; 12: 308–311.
  • Spertini O, Kansas GS, Munro JM, Griffin JD, Tedder TF. Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature 1991; 349: 691–694.
  • Squadrito F, Ioculano M, Altavilla D et al. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfu-sion injury. J Lipid Mediat 1993; 8: 53–65.
  • Stotland MA, Kerrigan CL. E- and L-selectin adhesion molecules in musculocutaneous flap reperfusion injury. Plast Reconstr Surg 1997; 99: 2010–2020.
  • Stotland MA, Kerrigan CL. The role of platelet-activating factor in musculocutaneous flap re-perfusion injury. Plast Reconstr Surg 1997; 99: 1989–1999.
  • Von Andrian UH, Chambers JD, Berg EL et al. L-selectin mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent and -independent recognition pathways. Blood 1993; 82: 182–191.
  • Von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci U S A 1991; 88: 7538–7542.
  • Yue TL, Rabinovici R, Feuerstein G. Platelet-activating factor (PAF) — a putative mediator in inflammatory tissue injury. Adv Exp Med Biol 1991; 314: 223–233.
  • Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529–540.
  • Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235–2246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.